In O O O O
what O O O O
is O O O O
thought O O O O
to O O O O
be O O O O
the O O O O
first O O O O
use O O O O
of O O O O
mRNA O O O O
for O O O O
an O O O O
allergic O O O O
disease, O O O O
scientists O O O O
from O O O O
the O O O O
University O O O O
of O O O O
California, O O O O
USA, O O O O
have O O O O
developed O O O O
a O O O O
novel O O O O
medicine O O O O
that O O O O
could O O O O
potentially O O O O
treat O O O O
peanut O O O O
allergies. O O O O
Taking O O O O
inspiration O O O O
from O O O O
COVID-19 O O O O
mRNA O O O O
vaccines O O O O
as O O O O
well O O O O
as O O O O
their O O O O
own O O O O
research O O O O
on O O O O
the O O O O
disease, O O O O
researchers O O O O
packaged O O O O
mRNA O O O O
inside O O O O
a O O O O
liver-targeting O O O O
lipid O O O O
nanoparticle, O O O O
which, O O O O
once O O O O
inside O O O O
the O O O O
liver, O O O O
'instructed' O O O O
specific O O O O
cells O O O O
to O O O O
tolerate O O O O
peanut O O O O
proteins. O O O O
Early O O O O
tests O O O O
have O O O O
shown O O O O
the Reason 5 O O
novel Reason 5 O O
medicine Reason 5 O O
alleviated Reason 5 O O
peanut Reason 5 O O
allergy Reason 5 O O
anaphylaxis Reason 5 O O
in Reason 5 O O
mice. Reason 5 O O
Excitingly, O O O O
immunological O O O O
activity O O O O
associated O O O O
with O O O O
allergic O O O O
responses O O O O
in O O O O
the O O O O
body, O O O O
including O O O O
Th2-mediated O O O O
cytokine O O O O
production, O O O O
IgE O O O O
synthesis, O O O O
and O O O O
mast O O O O
cell O O O O
release, O O O O
were O O O O
also O O O O
suppressed O O O O
by O O O O
the O O O O
medication. O O O O
The Reason 5 O O
use Reason 5 O O
of Reason 5 O O
mRNA Reason 5 O O
in Reason 5 O O
peanut Reason 5 O O
allergy Reason 5 O O
treatment Reason 5 O O
and Reason 5 O O
COVID-19 Reason 5 O O
vaccines Reason 5 O O
represents Reason 5 O O
a Reason 5 O O
breakthrough Reason 5 O O
in Reason 5 O O
the Reason 5 O O
field Reason 5 O O
of Reason 5 O O
medicine, Reason 5 O O
as Reason 5 O O
it Reason 5 O O
allows Reason 5 O O
researchers Reason 5 O O
to Reason 5 O O
develop Reason 5 O O
therapies Reason 5 O O
and Reason 5 O O
vaccines Reason 5 O O
that Reason 5 O O
can Reason 5 O O
be Reason 5 O O
quickly Reason 5 O O
and Reason 5 O O
easily Reason 5 O O
modified Reason 5 O O
to Reason 5 O O
target Reason 5 O O
different Reason 5 O O
diseases Reason 5 O O
and Reason 5 O O
conditions. Reason 5 O O
The Reason 5 O O
researchers Reason 5 O O
are Reason 5 O O
now Reason 5 O O
confident Reason 5 O O
that Reason 5 O O
their Reason 5 O O
peanut Reason 5 O O
allergy Reason 5 O O
treatment Reason 5 O O
will Reason 5 O O
go Reason 5 O O
to Reason 5 O O
clinical Reason 5 O O
trials Reason 5 O O
within Reason 5 O O
three Reason 5 O O
years, Reason 5 O O
and Reason 5 O O
that Reason 5 O O
it Reason 5 O O
has Reason 5 O O
the Reason 5 O O
potential Reason 5 O O
to Reason 5 O O
be Reason 5 O O
adapted Reason 5 O O
for Reason 5 O O
other Reason 5 O O
allergies Reason 5 O O
and Reason 5 O O
autoimmune Reason 5 O O
conditions. Reason 5 O O
For O O O O
more O O O O
information, O O O O
see O O O O
the O O O O
media O O O O
release O O O O
on O O O O
the O O O O
[University O O O O
